Move to topTop
August 08, 2014

Tokyo ― Terumo Corporation (TSE: 4543 Section 1) today announced that it has established a new corporate logo mark. The mark will gradually start being used from now on.

Background Information

After foundation in 1921, Terumo continues its business under the corporate mission of "Contributing to Society through Healthcare." With its recent shift to Company-led Management, Terumo is promoting its global operations than ever before. Towards the stakeholders around the world, the establishment of the new mark serves to show the company's determination in further contributing to healthcare over the next generations.

As a symbol of "Challenge for Innovation"

The concept of the new logo mark is "Challenge for Innovation." The design inherits value and confidence that Terumo has developed over the years, while also representing its strong will in taking challenges to generate innovations that help patients and medical practitioners. Keeping the new logo mark in their hearts, associates in the Terumo Group work together to further strive to realize the corporate mission.

New Corporate Logo Mark

  • The curved line extends from the left to right expresses a spirit of "Challenge for Innovation," with the aim of providing new value to the medical frontlines
  • The red color of the line indicates patients' lives as well as Terumo associates' passion
  • The curved shape of the line represents the arc of the Earth, which is an indication of Terumo's acceleration in its development of innovations
  • The green color of "TERUMO" shows unchanging values that Terumo has developed and continues to hold in the future

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.


Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.